HILL DERMACEUTICALS
PharmaHILL DERMACEUTICALS is a pharmaceutical company focused on Dermatology. Key products include TOLAK.
HILL DERMACEUTICALS's Key Drugs
HILL DERMACEUTICALS's core commercial portfolio centers on TOLAK, spanning Dermatology — its most strategically important drugs approved in the last 15 years.
HILL DERMACEUTICALS's Recent FDA Approvals
New NDA/BLA approvals for HILL DERMACEUTICALS over the last two years — novel drugs only, excluding generics and label supplements.
HILL DERMACEUTICALS's Therapeutic Areas
HILL DERMACEUTICALS's approved drugs and pipeline span 1 therapeutic area, led by Dermatology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
HILL DERMACEUTICALS's Top Competitors
HILL DERMACEUTICALS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
HILL DERMACEUTICALS Pipeline Snapshot
HILL DERMACEUTICALS has 1 active clinical program from ClinicalTrials.gov — 0 Phase 3, 0 Phase 2 and 1 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • TOLAK leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2015-09-18
- Latest
- 2022-08-25
- Applications
- 1